Literature DB >> 18625167

Statins and elevated liver tests: what's the fuss?

Edward Onusko1.   

Abstract

Order liver function tests before starting statin therapy, 12 weeks after initiation, with any dose increase, and periodically for long-term maintenance therapy. Mild elevations of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) (<3 times the upper limit of normal [ULN]) following statin therapy do not appear to lead to significant liver toxicity over time. Other medications that lower low-density lipoprotein (LDL), and might be substituted for statins, may not improve morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625167

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  4 in total

Review 1.  Clinical perspective: statins and the liver--harmful or helpful?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2012-05-12       Impact factor: 3.199

2.  Atorvastatin-induced prolonged cholestasis with bile duct damage.

Authors:  Manuela Merli; Maria Consiglia Bragazzi; Federica Giubilo; Francesco Callea; Adolfo F Attili; Domenico Alvaro
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.

Authors:  Bo Li; Asim Mahmood; Dunyue Lu; Hongtao Wu; Ye Xiong; Changsheng Qu; Michael Chopp
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

4.  A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice.

Authors:  Jun-jie Li; Marlein Miranda Cona; Yuan-bo Feng; Feng Chen; Guo-zhi Zhang; Xue-bin Fu; Uwe Himmelreich; Raymond Oyen; Alfons Verbruggen; Yi-cheng Ni
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.